Literature DB >> 15144022

Implementation of the European Laryngological Society (ELS) basic protocol for assessing voice treatment effect.

P H DeJonckere1, L Crevier-Buchman, J P Marie, M Moerman, M Remacle, V Woisard.   

Abstract

OBJECTIVES: 93 patients with various kinds of organic benign voice pathology (vocal fold nodules, polyp, Reinke's oedema, unilateral paralysis, sulcus/scar) and/or with muscle tension dysphonia, were evaluated before and after their voice treatment (phonosurgery with voice therapy, antireflux medication, or voice therapy alone) in order to check the clinical relevance of a basic multidimensional protocol for assessing functional results of voice treatments, as developed by the Committee on Phoniatrics of the ELS. MATERIAL AND
METHOD: The protocol has been used in different university voice clinics. It comprises 5 dimensions: Perception: Grade, Breathiness and Roughness from the GRBAS-scale, rated by two experienced judges: a phoniatrician/laryngologist and a speech therapist. Acoustics: Jitter % and Shimmer % computed on a /a:/, at comfortable loudness and pitch. Also Fo-range and softest possible intensity. Videostroboscopy: Glottal closure, regularity, mucosal wave and symmetry, rated separately. Phonation quotient: computed by dividing the vital capacity (ml) by the maximum phonation time (s) (best value of 2x3 trials). Self rating by the patient: voice quality in itself and general social/occupational handicap due to the voice problem rated separately.
RESULTS: Results show that, at group level, the overall effects for each parameter indicate a significant improvement after treatment. However, the correlations between the pre/post changes for the different parameters are weak (low redundancy).
CONCLUSION: The assessment of voice pathology needs to be multidimensional, as these multidimensional informations about voice changes lead to a better understanding of the actual way in which a treatment works.

Entities:  

Mesh:

Year:  2003        PMID: 15144022

Source DB:  PubMed          Journal:  Rev Laryngol Otol Rhinol (Bord)        ISSN: 0035-1334


  19 in total

1.  [Voice exercise therapy versus electrostimulation therapy in patients with unilateral vocal fold paralysis].

Authors:  M Ptok; D Strack
Journal:  HNO       Date:  2005-12       Impact factor: 1.284

2.  [Does the subjective assessment of roughness correlate with a computer-aided measurement of irregularity index?].

Authors:  M Ptok; C Iven; M Jessen; C Schwemmle
Journal:  HNO       Date:  2006-02       Impact factor: 1.284

3.  [On the auditory evaluation of voice quality].

Authors:  M Ptok; C Schwemmle; C Iven; M Jessen; T Nawka
Journal:  HNO       Date:  2006-10       Impact factor: 1.284

4.  [Medical treatment of singers' voices].

Authors:  B Richter; M Echternach
Journal:  HNO       Date:  2011-06       Impact factor: 1.284

5.  [Voice diagnostics in professional sopranos: application of the protocol of the European Laryngological Society (ELS)].

Authors:  M Echternach; S Arndt; M F Zander; B Richter
Journal:  HNO       Date:  2009-03       Impact factor: 1.284

Review 6.  [Laryngeal alterations following endotracheal intubation and use of larynx masks].

Authors:  M Echternach; T Mencke; B Richter; A Reber
Journal:  HNO       Date:  2011-05       Impact factor: 1.284

Review 7.  Rater methodology for stroboscopy: a systematic review.

Authors:  Heather Shaw Bonilha; Kendrea L Focht; Bonnie Martin-Harris
Journal:  J Voice       Date:  2014-09-26       Impact factor: 2.009

8.  The surgical treatment of unilateral vocal cord paralysis (UVCP): qualitative review analysis and meta-analysis study.

Authors:  F Granato; F Martelli; L V Comini; P Luparello; S Coscarelli; O Le Seac; S Carucci; P Graziani; R Santoro; G Alderotti; M R Barillari; Giuditta Mannelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-02       Impact factor: 2.503

9.  [Treatment of glottal gap].

Authors:  S Voigt-Zimmermann; C Arens
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

10.  [Effects of different tasks on determination of the speaking fundamental frequency].

Authors:  B Barsties
Journal:  HNO       Date:  2013-07       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.